Matsumoto G, Hisamitsu T, de Groat W C
Department of Pharmacology, University of Pittsburgh, School of Medicine, PA 15261, USA.
Neurosci Lett. 1995 Jan 2;183(1-2):58-61. doi: 10.1016/0304-3940(94)11114-x.
MK-801, an NMDA receptor antagonist administered intravenously or intrathecally to the L6-S1 spinal cord inhibited in a dose dependent manner the amplitude of isovolumetric bladder contractions evoked by electrical stimulation in the pontine micturition center (PMC) in urethane anesthetized rats. The mean threshold dose of MK-801 was 10 +/- 6 micrograms/kg i.v. and 10 +/- 1 micrograms i.t. Bladder contractions were completely inhibited at doses ranging from 300 to 3000 micrograms/kg i.v. and from 18 to 48 micrograms i.t. These data indicate that NMDA glutamatergic receptors play an important role in excitatory transmission in the descending pathway from the PMC to the spinal segmental circuitry involved in the control of the urinary bladder.
MK-801是一种N-甲基-D-天冬氨酸(NMDA)受体拮抗剂,对氨基甲酸乙酯麻醉的大鼠,经静脉或鞘内注射到L6-S1脊髓,以剂量依赖性方式抑制脑桥排尿中枢(PMC)电刺激诱发的等容膀胱收缩幅度。MK-801的平均阈剂量静脉注射为10±6微克/千克,鞘内注射为10±1微克。静脉注射剂量为300至3000微克/千克和鞘内注射剂量为18至48微克时,膀胱收缩被完全抑制。这些数据表明,NMDA谷氨酸能受体在从PMC到参与膀胱控制的脊髓节段回路的下行通路的兴奋性传递中起重要作用。